This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Karo Pharma Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 1/6
Wichtige Informationen
104.8%
Verhältnis von Schulden zu Eigenkapital
kr8.65b
Verschuldung
| Zinsdeckungsgrad | 0.2x |
| Bargeld | kr353.10m |
| Eigenkapital | kr8.26b |
| Gesamtverbindlichkeiten | kr10.24b |
| Gesamtvermögen | kr18.49b |
Jüngste Berichte zur Finanzlage
Karo Pharma (STO:KARO) Has No Shortage Of Debt
Oct 14
Is Karo Pharma (STO:KARO) A Risky Investment?
Jul 10Karo Pharma (STO:KARO) Seems To Be Using A Lot Of Debt
Mar 23Recent updates
Karo Pharma (STO:KARO) Has No Shortage Of Debt
Oct 14Is Karo Pharma (STO:KARO) A Risky Investment?
Jul 10Karo Pharma (STO:KARO) Seems To Be Using A Lot Of Debt
Mar 23Karo Pharma's (STO:KARO) Strong Earnings Are Of Good Quality
Feb 24Is Karo Pharma AB (publ)'s (STO:KARO) 1.5% ROE Worse Than Average?
Feb 22Did You Participate In Any Of Karo Pharma's (STO:KARO) Fantastic 144% Return ?
Feb 01
Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: KARO's short term assets (SEK1.7B) exceed its short term liabilities (SEK626.0M).
Langfristige Verbindlichkeiten: KARO's short term assets (SEK1.7B) do not cover its long term liabilities (SEK9.6B).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: KARO's net debt to equity ratio (100.5%) is considered high.
Schulden abbauen: KARO's debt to equity ratio has increased from 59.5% to 104.8% over the past 5 years.
Schuldendeckung: KARO's debt is not well covered by operating cash flow (5.9%).
Zinsdeckung: KARO's interest payments on its debt are not well covered by EBIT (0.2x coverage).